Detailed Information on Publication Record
2007
Increased activity of superoxid dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases
SALZMAN, Richard, Kateřina KAŇKOVÁ, Lukáš PÁCAL, Josef TOMANDL, Kateřina ŠÍROVÁ et. al.Basic information
Original name
Increased activity of superoxid dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases
Name in Czech
Increased activity of superoxid dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases
Authors
SALZMAN, Richard (703 Slovakia, guarantor, belonging to the institution), Kateřina KAŇKOVÁ (203 Czech Republic, belonging to the institution), Lukáš PÁCAL (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Kateřina ŠÍROVÁ (203 Czech Republic) and Rom KOSTŘICA (203 Czech Republic, belonging to the institution)
Edition
Neoplasma, Blarislava, Slovakia, Slovak Academy of Sciences, 2007, 0028-2685
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 1.208
RIV identification code
RIV/00216224:14110/07:00019091
Organization unit
Faculty of Medicine
UT WoS
000251196300009
Keywords in English
antioxidative enzymes; head and neck cancer; metastasis; oxidative stress; polymorphism; syuperoxide dismutase
Tags
Tags
International impact, Reviewed
Změněno: 6/6/2012 08:39, doc. RNDr. Josef Tomandl, Ph.D.
V originále
Our results suggest that increased p-SOD at the time of the initial treatment for HNSCC is connected with a greater extent and nodal metastatic spread of the initial disease and an earlier disease relapse. Progression of diseases might be further modified by the presence of Ala/Ala genotype of the SOD2. Activity of p-SOD could thus offer diagnostic as well as prognostic value.
In Czech
Our results suggest that increased p-SOD at the time of the initial treatment for HNSCC is connected with a greater extent and nodal metastatic spread of the initial disease and an earlier disease relapse. Progression of diseases might be further modified by the presence of Ala/Ala genotype of the SOD2. Activity of p-SOD could thus offer diagnostic as well as prognostic value.
Links
| NR7996, research and development project |
|